Innovative Research

What Innovative Research does

Innovative Research of West Florida, Inc. is a privately held, founder-owned clinical research site headquartered at 1573 S Fort Harrison Ave, Clearwater, FL. Founded in 2002 by Miguel Trevino, MD (Principal Investigator, Internal Medicine) and Tracey Osborn, DHA, MBA, BSN, CCRC (Research Director), the company operates as a Phase I–IV clinical trial site serving pharmaceutical sponsors and contract research organizations. Dr. Trevino has cumulatively conducted more than 300 trials as Principal Investigator since 2002, and the facility is staffed by 12+ personnel including a second physician (Dr. Timothy Light, DO, Sub-Investigator), clinical research coordinators, recruitment specialists, a lab manager, an office manager, and an IT director.

The company delivers its core service — clinical trial execution — across 15+ therapeutic areas, including cardiology, dermatology, endocrinology, gastroenterology, pulmonology, rheumatology, neurology, urology, and vaccines. Its technical footprint is built around conventional clinical research equipment: syringe pumps, IV pumps, Mortara EKG machines, Holter monitors, electronic consent platforms, electronic patient diaries, and a COVID-19 testing capability (Cepheid GeneXpert Express PCR and BD Veritor rapid antigen testing) operated in a drive-through format. Trial offerings span weight loss / GLP-1 receptor agonists, asthma, COPD, chronic cough, hypertension, triglycerides, congestive heart failure, heart failure with iron deficiency, neurogenic orthostatic hypotension, diabetic peripheral neuropathy (REGAiN-1A with Helixmith), diabetic gastroparesis, atopic dermatitis, essential tremors, arthritis, mastocytosis, and COVID-19 treatment.

Innovative Research generates revenue by enrolling patients, administering investigational treatments, collecting data, and reporting outcomes to pharma sponsors and CROs pursuing FDA approvals — i.e., a professional-services model with project-based contracting per trial rather than recurring SaaS or retainer revenue. Patient recruitment is driven by community outreach, the affiliated Premier family and internal medicine practice (co-located at the same address), word-of-mouth, and an online presence spanning the company website plus Facebook, Instagram, YouTube, and X/Twitter channels. Named sponsor and CRO relationships include Pfizer, Eli Lilly, AstraZeneca, Novartis, AbbVie, Novo Nordisk, Amgen, Sanofi Pasteur, Roche, GSK, Takeda, Bayer, Boehringer Ingelheim, Regeneron, and Lundbeck on the sponsor side, and Medpace, IQVIA, ICON, Premier Research, Labcorp Drug Development, and Clario on the CRO side. Pricing is not publicly disclosed; participant compensation is structured per trial (e.g., the triglycerides trial offers up to $900 across 12 visits).

Name

Innovative Research

Legal name

Innovative Research of West Florida, Inc.

Website

https://innovativeresearchfl.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

Innovative Research of West Florida is a privately held, founder-owned Phase I–IV clinical research site in Clearwater, FL, founded in 2002, conducting 300+ trials across 15+ therapeutic areas for pharmaceutical sponsors and CROs including Pfizer, Eli Lilly, and IQVIA.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Clinical research services
• Phase I-IV trials
• Clinical trial site
• Principal investigator services
• Therapeutic area trials

Headquarters

HQ city

Clearwater

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services for Pharmaceutical Sponsors: Innovative Research conducts clinical trials on behalf of pharmaceutical companies and CROs across Phase I-IV. The company earns revenue by enrolling patients, administering investigational treatments, collecting data, and reporting outcomes to sponsors pursuing FDA approvals. Their therapeutic areas include cardiology, pulmonology, dermatology, endocrinology, gastroenterology, rheumatology, neurology, urology, and vaccines.
2. Patient Recruitment and Participation Compensation: Eligible clinical trial participants may receive compensation for their time and travel (e.g., triglycerides trial offers up to $900, $75 per visit, 12 visits). While this represents a cost to the company, it enables patient enrollment that supports sponsor-funded research revenue.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Innovative Research of West Florida operates a single-site clinical research facility that conducts Phase I-IV clinical trials on behalf of pharmaceutical sponsors and contract research organizations (CROs) across 15+ therapeutic areas, including cardiology, dermatology, endocrinology, gastroenterology, pulmonology, rheumatology, neurology, urology, and vaccines. The site recruits patients for individual studies, administers investigational treatments, collects clinical data, and reports outcomes to sponsors pursuing FDA approvals. Adjacent services include drive-through COVID-19 PCR and antigen testing and pulmonary function testing for respiratory trials.

Product overview

Innovative Research of West Florida operates as a single unified clinical research platform offering Phase I-IV clinical trial services. The core offering is Clinical Trials Services, supported by specialized therapeutic trial modules across 15+ conditions including weight loss (with GLP-1 receptor agonists), respiratory conditions (asthma, COPD, chronic cough), cardiovascular conditions (heart failure, hypertension, triglycerides), neurological conditions (essential tremors, diabetic peripheral neuropathy, neurogenic orthostatic hypotension), dermatology (atopic dermatitis/eczema), diabetes-related conditions (diabetic gastroparesis, diabetic peripheral neuropathy), and vaccines (COVID-19, RSV, seasonal flu). Additional services include COVID-19 testing using BD Veritor and Cepheid GeneXpert Express machines, and pulmonary function testing. The company has conducted over 300 trials as a Principal Investigator since 2002 and works with major pharmaceutical partners including Novo Nordisk, Amgen, Pfizer, Eli Lilly, and others.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials Services Phase I-IV clinical trial services for pharmaceutical sponsors and CROs across multiple therapeutic areas including cardiology, dermatology, endocrinology, gastroenterology, pulmonology, rheumatology, neurology, urology, and vaccines. Includes patient recruitment, administration of investigational treatments, data collection, and outcomes reporting for FDA approval purposes.
• COVID-19 Testing Services Rapid COVID-19 antigen and PCR testing offered via drive-through sample collection at the Clearwater, FL facility, using BD Veritor (15-minute results) and Cepheid GeneXpert Express (under 45 minutes) machines.
• Pulmonary Function Testing Respiratory/pulmonary function testing services conducted at the Clearwater facility in support of COPD, asthma, and other breathing-related clinical trials.
• Mastocytosis Clinical Trial Clinical trial evaluating an investigational medication for patients diagnosed with mastocytosis.
• Asthma Clinical Trial Clinical trial for patients diagnosed with asthma, with or without regular inhaler therapy use; eligible participants may be compensated for time and travel.
• COPD Clinical Trial Clinical trial for patients diagnosed with mild-to-moderate COPD seeking new treatment options.
• Weight Loss Clinical Trial Clinical trial for potential weight loss medications including GLP-1 receptor agonists, leveraging 20+ years of experience in weight management therapies.
• Triglycerides Clinical Trial (bio89 Study) Clinical study of an investigational drug designed to potentially reduce triglyceride levels in patients with levels above 400 mg/dL; eligible participants may be compensated up to $900 ($75 per visit, 12 visits).
• High Blood Pressure (Hypertension) Clinical Trial Clinical trial for an investigational vaccine targeting patients with a history of hypertension.
• Congestive Heart Failure Clinical Trial Clinical trial for an investigational medication targeting congestive heart failure patients.
• Heart Failure with Iron Deficiency (Anemia) Clinical Trial Clinical study evaluating investigational intravenous (IV) iron therapy to treat heart failure with iron deficiency, including echocardiogram and cardiology lab work for participants.
• Neurogenic Orthostatic Hypotension Clinical Trial Clinical trial studying long-term effectiveness of FDA-approved NORTHERA (droxidopa) for NOH patients with Parkinson's disease, multiple system atrophy, or pure autonomic failure.
• Diabetic Peripheral Neuropathy Clinical Trial (REGAiN-1A Study) Clinical study of an investigational drug designed to potentially relieve pain caused by diabetic peripheral neuropathy, conducted in partnership with Helixmith.
• Diabetic Gastroparesis Clinical Trial Clinical trial for an investigational oral medication targeting patients experiencing gastroparesis symptoms including slow digestion, bloating, and nausea.
• Atopic Dermatitis/Eczema Clinical Trial Phase III clinical trial evaluating safety and effectiveness of an investigational oral study medication for itching associated with atopic dermatitis in adults.
• Essential Tremors Clinical Trial Clinical trial investigating a new possible treatment option for patients experiencing essential tremors as part of FDA approval requirements.
• Arthritis Clinical Trial Clinical trial for an investigational medication targeting arthritis patients experiencing pain and stiffness from joint inflammation.
• Chronic Cough Clinical Trial Clinical trial investigating new medications with possible benefits for individuals with chronic cough, leveraging experience in advanced breathing medications and inhaler designs.
• COVID-19 Treatment Clinical Trial Clinical trial for an investigational medication for SARS-CoV-2 infected patients, with experience in COVID-19 antibody treatments and novel virus vaccines.

Quantifiable outcome

• Participants may be compensated up to $900 for triglycerides trial participation ($75 per visit, 12 visits)
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature4 records

Partnerships

31 partnerships are on record, tiered core and minor.

• Novo NordiskcoreStrategic or Co-development PartnerNovo Nordisk is listed as a pharmaceutical partner of Innovative Research. The company has experience conducting clinical trials for diabetes and weight management medications, including GLP-1 receptor agonists.
• AmgencoreStrategic or Co-development PartnerAmgen is listed as a pharmaceutical partner with experience in cardiovascular indication clinical trials.
• PfizercoreStrategic or Co-development PartnerPfizer is listed as a pharmaceutical partner with experience across multiple therapeutic areas.
• RochecoreStrategic or Co-development PartnerRoche is listed as a pharmaceutical partner with experience in cardiovascular and other indications.
• Eli LillycoreStrategic or Co-development PartnerEli Lilly is listed as a pharmaceutical partner. Innovative Research has direct experience working on cardiac medications from Eli Lilly. Also experienced with weight and appetite management drugs including GLP-1 receptor agonists.
• GlaxoSmithKlinecoreStrategic or Co-development PartnerGlaxoSmithKline is listed as a pharmaceutical partner with experience across vaccines and other therapeutic areas.
• Sanofi PasteurcoreStrategic or Co-development PartnerSanofi Pasteur is listed as a pharmaceutical partner with vaccine trial experience.
• AstraZenecacoreStrategic or Co-development PartnerAstraZeneca is listed as a pharmaceutical partner with experience across multiple therapeutic areas.
• RegeneroncoreStrategic or Co-development PartnerRegeneron is listed as a pharmaceutical partner.
• AbbViecoreStrategic or Co-development PartnerAbbVie is listed as a pharmaceutical partner.
• NovartiscoreStrategic or Co-development PartnerNovartis is listed as a pharmaceutical partner. Innovative Research has direct experience working on cardiac medications from Novartis.
• HelixmithcoreStrategic or Co-development PartnerHelixmith is listed as a pharmaceutical partner. The REGAiN-1A clinical trial for diabetic peripheral neuropathy is conducted in partnership with Helixsmith. Innovative Research works directly with Helixmith on this neuropathy study.
• MedpacecoreChannel Partner/ Reseller/ DistributorMedpace is a CRO (Contract Research Organization) listed as a partner. They engage Innovative Research for site-level clinical trial execution.
• ICON PLCcoreChannel Partner/ Reseller/ DistributorICON PLC is a CRO listed as a partner, engaging Innovative Research for clinical trial site services.
• IQVIAcoreChannel Partner/ Reseller/ DistributorIQVIA is a CRO listed as a partner, engaging Innovative Research for clinical trial site services.
• Labcorp Drug DevelopmentcoreChannel Partner/ Reseller/ DistributorLabcorp Drug Development is a CRO listed as a partner, engaging Innovative Research for clinical trial site services.
• Premier ResearchcoreChannel Partner/ Reseller/ DistributorPremier Research is a CRO listed as a partner.
• Daiichi-SankyocoreStrategic or Co-development PartnerDaiichi-Sankyo is listed as a pharmaceutical partner.
• AbbottcoreStrategic or Co-development PartnerAbbott is listed as a pharmaceutical partner with cardiovascular and diagnostic experience.
• TakedacoreStrategic or Co-development PartnerTakeda is listed as a pharmaceutical partner.
• Boehringer IngelheimcoreStrategic or Co-development PartnerBoehringer Ingelheim is listed as a pharmaceutical partner.
• AmarincoreStrategic or Co-development PartnerAmarin is listed as a pharmaceutical partner.
• AstellascoreStrategic or Co-development PartnerAstellas is listed as a pharmaceutical partner.
• LundbeckcoreStrategic or Co-development PartnerLundbeck is listed as a pharmaceutical partner.
• TevacoreStrategic or Co-development PartnerTeva is listed as a pharmaceutical partner.
• BayercoreStrategic or Co-development PartnerBayer is listed as a pharmaceutical partner.
• LupincoreStrategic or Co-development PartnerLupin is listed as a pharmaceutical partner.
• ViatriscoreStrategic or Co-development PartnerViatris is listed as a pharmaceutical partner.
• UrovantminorStrategic or Co-development PartnerUrovant is listed as a pharmaceutical partner in urology.
• Kyowa KirinminorStrategic or Co-development PartnerKyowa Kirin is listed as a pharmaceutical partner.
• CiplaminorStrategic or Co-development PartnerCipla is listed as a pharmaceutical partner.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Medpace: Global mid-sized CRO that partners with Innovative Research for site-level trial execution; operates as a broader incumbent clinical research services provider across all phases and therapeutic areas, complementing the site-level offering.
• Labcorp Drug Development: Large clinical development services organization with central laboratory and site services; engages Innovative Research as a site partner and competes broadly for clinical research services budgets.
• Premier Research: Mid-size CRO with specialized clinical trial services across multiple therapeutic areas; listed as a CRO partner of Innovative Research and provides an incumbent benchmark for sponsor-facing services.
• ICON plc: Global CRO with site services and clinical operations capabilities across therapeutic areas; partnered with Innovative Research for site execution and represents an incumbent comparator.
• IQVIA: World's largest CRO with site management and investigator network capabilities; engages Innovative Research as a site partner and represents the broader incumbent that defines sponsor expectations for site performance and quality.

Direct peers

• Aventiv Research: Mid-size independent SMO conducting Phase I-IV trials across a broad therapeutic-area footprint for pharma and CRO clients; comparable site-based clinical trial services model with similar sponsor mix.
• Wake Research: Multi-site clinical research site network (SMO) operating across the U.S. with Phase I-IV capabilities across multiple therapeutic areas; directly comparable business model to Innovative Research as a multi-specialty trial site serving pharma sponsors and CROs.
• Accel Research Sites: Multi-site clinical research network conducting Phase I-IV trials across therapeutic areas including CNS, vaccines, dermatology, and cardiometabolic indications; directly comparable site-based SMO operating model.
• Benchmark Research: Independent clinical research site conducting Phase I-IV trials across cardiology, vaccines, dermatology, and other therapeutic areas; comparable site-based SMO model with similar sponsor relationships.
• Meridien Research: Florida-based independent clinical research site network operating across multiple therapeutic areas; directly comparable in geographic base (Florida), site-based operations, and Phase II-IV trial portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/InnovResearchFL
• YouTubeyoutube.com/channel/UCj9bebXBM22rnN3M6UxZ9UQ
• Facebookfacebook.com/InnovativeResearchFL
• Instagraminstagram.com/innovativeResearchFL
• LinkedInlinkedin.com/company/innovative-research-of-west-florida

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovative Research